Orally Active Isoxazoline Glycoprotein IIb/IIIa Antagonists with Extended Duration of Action
- 12 March 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 42 (7) , 1178-1192
- https://doi.org/10.1021/jm980348t
Abstract
Modification of the α-carbamate substituent of isoxazoline GPIIb/IIIa (αIIbβ3) antagonist DMP 754 (7) led to a series of α-sulfonamide and α-sulfamide diaminopropionate isoxazolinylacetamides which were found to be potent inhibitors of in vitro platelet aggregation. Aryl- and heteroaryl-α-sulfonamide groups, in conjunction with (5R)-isoxazoline (2S)-diaminopropionate stereochemistry, were found to impart a pronounced duration of antiplatelet effect in dogs, potentially due to high affinity for unactivated platelets. Isoxazolylsulfonamide 34b (DMP 802), a highly selective GPIIb/IIIa antagonist, demonstrated a prolonged duration of action after iv and po dosing and high affinity for resting and activated platelets. The prolonged antiplatelet profile of DMP 802 in dogs and the high affinity of DMP 802 for human platelets may be predictive of clinical utility as a once-daily antiplatelet agent.Keywords
This publication has 18 references indexed in Scilit:
- Nonpeptide GPIIB/IIIA inhibitors. 16. Thieno[2,3-b]thiophene α-sulfonamides are potent inhibitors of platelet aggregationBioorganic & Medicinal Chemistry Letters, 1997
- Nonpeptide glycoprotein IIb/IIIa inhibitors: 18. Indole alpha-sulfonamide acids are potent inhibitors of platelet aggregationBioorganic & Medicinal Chemistry Letters, 1997
- Non-Peptide Glycoprotein IIb/IIIa Inhibitors. 17. Design and Synthesis of Orally Active, Long-Acting Non-Peptide Fibrinogen Receptor AntagonistsJournal of Medicinal Chemistry, 1997
- New antiplatelet drugsEmerging Drugs, 1997
- Nonpeptide glycoprotein IIB/IIIA inhibitors. 12. Potent and orally active centrally constrained thieno[2,3-c]pyridonesBioorganic & Medicinal Chemistry Letters, 1996
- Novel nonpeptide antiplatelet glycoprotein llb/llla receptor antagonist, DMP754Coronary Artery Disease, 1996
- Relationships Between CSF Drug Concentrations, Receptor Binding Characteristics, and Pharmacokinetic and Pharmacodynamic Properties of Selected 1,4-Substituted BenzodiazepinesClinical Pharmacokinetics, 1987
- Potential inhibitors of L-asparagine biosynthesis. 5. Electrophilic amide analogs of (S)-2,3-diaminopropionic acidJournal of Medicinal Chemistry, 1981
- An improved synthesis of sulfamoyl chloridesThe Journal of Organic Chemistry, 1976
- Sulfamoyl azides. Hydrolysis rates and hypotensive activityJournal of Medicinal Chemistry, 1972